Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma

被引：7
|
作者：
Dias, Amanda de Fraga [1 ]
Dallemole, Danieli Rosane [2 ]
Bruinsmann, Franciele Aline [2 ]
Lopes Silva, Luiz Fernando [1 ]
Cruz-Lopez, Olga [3 ,4 ]
Conejo-Garcia, Ana [3 ,4 ]
Oliveira Battastini, Ana Maria [1 ]
Maria Campos, Joaquin [3 ,4 ]
Guterres, Silvia Staniscuaski [2 ]
Pohlmann, Adriana Raffin [2 ]
Figueiro, Fabricio [1 ,5 ]
机构：
[1] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil
[3] Fac Farm, Dept Quim Farmaceut & Organ, C Campus Cartuja S-N, Granada, Spain
[4] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain
[5] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil
来源：
NANOMEDICINE | 2021年 / 16卷 / 23期
关键词：
bozepinib; drug delivery; glioblastoma; intranasal; lipid-core nanocapsules; temozolomide; LIPID-CORE NANOCAPSULES; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; INTRANASAL DELIVERY; EXPERIMENTAL-DESIGN; GROWTH-INHIBITION; IN-VITRO; CHITOSAN; COMBINATION; GLIOMA;
D O I：
10.2217/nnm-2021-0164
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: To develop and characterize bozepinib-loaded lipid-core nanocapsules (BZP-LNC+) as a potential treatment for glioblastoma (GBM). Methods: Characterization of nanocapsules was performed by diameter, polydispersity index, zeta potential, pH and encapsulation efficiency. GBM cell viability, cell cycle and Annexin/PI were evaluated after BZP-LNC+ treatment. Synergism between BZP-LNC+ and temozolomide (TMZ) was performed by CompuSyn software and confirmed in vitro and in vivo. Results: BZP-LNC+ showed adequate particle sizes, positive zeta potential, narrow size distribution and high encapsulation efficiency. BZP-LNC+ reduces GBM growth by inducing apoptosis. BZP-LNC+ and TMZ showed synergistic effect in vitro and reduced the in vivo glioma growth by approximately 81%. Conclusion: The present study provides proof-of-principle insights for the combination of these drugs for GBM treatment.
引用
收藏
页码：2095 / 2115
页数：21
相关论文
共 50 条
  • [41] Nanoparticles for direct nose-to-brain delivery of drugs
    Mistry, Alpesh
    Stolnik, Snjezana
    Illum, Lisbeth
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 379 (01) : 146 - 157
  • [42] Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug
    Alam, M. Intakhab
    Baboota, Sanjula
    Ahuja, Alka
    Ali, Mushir
    Ali, Javed
    Sahni, Jasjeet K.
    Bhatnagar, Aseem
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 470 (1-2) : 99 - 106
  • [43] Modeling brain pathology to study nose-to-brain drug delivery
    Talgatkyzy, Altynay
    Khaibullin, Talgat
    Syzdykbayev, Marat
    Kazymov, Maksut
    Sharapiyeva, Alua
    Amrenova, Kuralay
    Dinara, Shagiyeva
    Toktabayeva, Bakytkul
    Khamitova, Meruyert
    Apsalikov, Bakytbek
    Ozhmukhametova, Elvira
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (07): : 435 - 440
  • [44] Formulation and evaluation of nasal insert for nose-to-brain drug delivery of rivastigmine tartrate
    Shaghlil, Lena
    Alshishani, Anas
    Abu Sa'aleek, Asmaa
    Abdelkader, Hamdy
    Al-ebini, Yousef
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 76
  • [45] Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G
    Mwema, Ariane
    Bottemanne, Pauline
    Paquot, Adrien
    Ucakar, Bernard
    Vanvarenberg, Kevin
    Alhouayek, Mireille
    Muccioli, Giulio G.
    des Rieux, Anne
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2023, 48
  • [46] Nose-to-Brain Delivery: Evaluation of Polymeric Nanoparticles on Olfactory Ensheathing Cells Uptake
    Musumeci, Teresa
    Pellitteri, Rosalia
    Spatuzza, Michela
    Puglisi, Giovanni
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (02) : 628 - 635
  • [47] An update on the role of nanovehicles in nose-to-brain drug delivery
    Feng, Yunhai
    He, Haisheng
    Li, Fengqian
    Lu, Yi
    Qi, Jianping
    Wu, Wei
    DRUG DISCOVERY TODAY, 2018, 23 (05) : 1079 - 1088
  • [48] Nose-to-brain delivery of nanotherapeutics: Transport mechanisms and applications
    Xu, Kunyao
    Duan, Suqin
    Wang, Wenjing
    Ouyang, Qiuhong
    Qin, Feng
    Guo, Peilin
    Hou, Jinghan
    He, Zhanlong
    Wei, Wei
    Qin, Meng
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2024, 16 (02)
  • [49] Nose-to-brain delivery of antipsychotics using nanotechnology: a review
    Tan, Madeleine S. A.
    Parekh, Harendra S.
    Pandey, Preeti
    Siskind, Dan J.
    Falconer, James R.
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (06) : 839 - 853
  • [50] Nanoparticles for Direct Nose-to-Brain Delivery of Gene Therapy
    Sanchez-Ramos, J.
    Song, S.
    Sava, V.
    NEUROTHERAPEUTICS, 2015, 12 (03) : 681 - 682
12345